SOCM

SR One Capital Management Portfolio holdings

AUM $461M
1-Year Est. Return 23.25%
This Quarter Est. Return
1 Year Est. Return
+23.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$461M
AUM Growth
+$72.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
13
New
Increased
Reduced
Closed

Top Buys

1
+$45.8M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX icon
1
Arcellx
ACLX
$5.01B
$155M 33.49%
2,346,630
SPRY icon
2
ARS Pharmaceuticals
SPRY
$885M
$70M 15.18%
4,012,903
CRSP icon
3
CRISPR Therapeutics
CRSP
$5.82B
$51M 11.06%
1,048,951
ZBIO
4
Zenas BioPharma
ZBIO
$1.47B
$47.6M 10.32%
4,911,539
ORIC icon
5
Oric Pharmaceuticals
ORIC
$1.28B
$45.8M 9.93%
+4,514,929
MLYS icon
6
Mineralys Therapeutics
MLYS
$3.17B
$42.3M 9.17%
3,127,933
DSGN icon
7
Design Therapeutics
DSGN
$382M
$22M 4.77%
6,526,476
OCS icon
8
Oculis Holding
OCS
$1.01B
$6.26M 1.36%
322,500
ALMS
9
Alumis Inc
ALMS
$494M
$5.88M 1.27%
1,959,896
NKTX icon
10
Nkarta
NKTX
$150M
$5.53M 1.2%
3,333,333
ORKA
11
Oruka Therapeutics
ORKA
$1.36B
$4.82M 1.05%
430,330
KALA icon
12
KALA BIO
KALA
$5.48M
$2.85M 0.62%
598,940
ENGN icon
13
enGene Holdings
ENGN
$369M
$2.72M 0.59%
747,750